Psybio Therapeutics Corp Stock Filter Stocks by Fundamentals
| PSYBF Stock | USD 0.0001 0.00 0.00% |
PsyBio Therapeutics Corp fundamentals help investors to digest information that contributes to PsyBio Therapeutics' financial success or failures. It also enables traders to predict the movement of PsyBio Pink Sheet. The fundamental analysis module provides a way to measure PsyBio Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PsyBio Therapeutics pink sheet.
PsyBio |
Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
PsyBio Fundamentals
| Return On Equity | -3.1 | |||
| Return On Asset | -0.98 | |||
| Current Valuation | 3.69 M | |||
| Shares Outstanding | 80.85 M | |||
| Shares Owned By Insiders | 25.61 % | |||
| Shares Owned By Institutions | 13.23 % | |||
| Price To Book | 202.42 X | |||
| Gross Profit | (1.56 M) | |||
| EBITDA | (10.91 M) | |||
| Net Income | (11.02 M) | |||
| Cash And Equivalents | 911.83 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 207.81 K | |||
| Debt To Equity | 7.03 % | |||
| Current Ratio | 0.89 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (6.95 M) | |||
| Earnings Per Share | (0.09) X | |||
| Market Capitalization | 4.94 M | |||
| Total Asset | 4.01 M | |||
| Z Score | 7.2 | |||
| Net Asset | 4.01 M |
About PsyBio Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PsyBio Therapeutics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PsyBio Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PsyBio Therapeutics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in PsyBio Pink Sheet
PsyBio Therapeutics financial ratios help investors to determine whether PsyBio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PsyBio with respect to the benefits of owning PsyBio Therapeutics security.